Talphera Trades Around 80 Cents With Focus on Single Trial Catalyst
Talphera Inc. traded at about $0.80 early Wednesday, off 2.8% from its last close. Only 1,493 shares traded as the company’s market cap hovered near $41.5 million. The stock lagged behind a stronger biotech sector, with SPDR S&P Biotech ETF up 0.9% and iShares Nasdaq Biotechnology ETF adding 0.8%. An ETF is a basket of securities that trades like a single stock. Talphera’s most recent update was still its May 13 Q1 results and a corporate update, according to the investor page. Investors were left focused on trial timing, cash position, and when new data might hit, with no fresh announcement from the company.